Dirk Grimm

Affiliations: 
Heidelberg University Hospital 
Area:
RNAi, gene therapy, AAV, iPS cells, genome engineering
Google:
"Dirk Grimm"
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Theuerkauf SA, Herrera-Carrillo E, John F, et al. (2023) AAV vectors displaying bispecific DARPins enable dual-control targeted gene delivery. Biomaterials. 303: 122399
Liu J, Koay TW, Maiakovska O, et al. (2023) Progress in Bioengineering of Myotropic Adeno-Associated Viral Gene Therapy Vectors. Human Gene Therapy. 34: 350-364
Rapti K, Maiakovska O, Becker J, et al. (2022) Isolation of Next-Generation Gene Therapy Vectors through Engineering, Barcoding, and Screening of Adeno-Associated Virus (AAV) Capsid Variants. Journal of Visualized Experiments : Jove
Szumska J, Grimm D. (2022) Boosters for adeno-associated virus vector (AAV) (r)evolution. Cytotherapy
Becker J, Fakhiri J, Grimm D. (2022) Fantastic AAV Gene Therapy Vectors and How to Find Them-Random Diversification, Rational Design and Machine Learning. Pathogens (Basel, Switzerland). 11
Mann AM, Schäfer W, Adriouch S, et al. (2022) Enhanced Transduction of P2X7-Expressing Cells with Recombinant rAAV Vectors. Methods in Molecular Biology (Clifton, N.J.). 2510: 129-144
Gadenstaetter AJ, Schmutzler L, Grimm D, et al. (2022) Intranasal application of adeno-associated viruses: a systematic review. Translational Research : the Journal of Laboratory and Clinical Medicine
Becker J, Stanifer ML, Leist SR, et al. (2022) Ex vivo and in vivo suppression of SARS-CoV-2 with combinatorial AAV-RNAi expression vectors. Molecular Therapy : the Journal of the American Society of Gene Therapy
Michels A, Frank AM, Günther DM, et al. (2021) Lentiviral and adeno-associated vectors efficiently transduce mouse T lymphocytes when targeted to murine CD8. Molecular Therapy. Methods & Clinical Development. 23: 334-347
Zhang C, Freistaedter A, Schmelas C, et al. (2021) An RNA Interference/Adeno-Associated Virus Vector-Based Combinatorial Gene Therapy Approach Against Hepatitis E Virus. Hepatology Communications
See more...